Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.

Ngeow J, Eng C.

NPJ Genom Med. 2016 Jan 13;1:15006. doi: 10.1038/npjgenmed.2015.6. eCollection 2016.

2.

Clinician-Stakeholders' Perspectives on Using Patient Portals to Return Lynch Syndrome Screening Results.

Korngiebel DM, West KM, Burke W.

J Genet Couns. 2018 Apr;27(2):349-357. doi: 10.1007/s10897-017-0179-3. Epub 2017 Nov 21.

PMID:
29159545
3.

Germline Genetic Features of Young Individuals With Colorectal Cancer.

Stoffel EM, Koeppe E, Everett J, Ulintz P, Kiel M, Osborne J, Williams L, Hanson K, Gruber SB, Rozek LS.

Gastroenterology. 2018 Mar;154(4):897-905.e1. doi: 10.1053/j.gastro.2017.11.004. Epub 2017 Nov 14.

PMID:
29146522
4.

Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.

Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF.

JAMA Oncol. 2018 Feb 8;4(2):e173580. doi: 10.1001/jamaoncol.2017.3580. Epub 2018 Feb 8.

PMID:
29121143
5.

A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification.

Tognetto A, Michelazzo MB, Calabró GE, Unim B, Di Marco M, Ricciardi W, Pastorino R, Boccia S.

Front Public Health. 2017 Sep 12;5:243. doi: 10.3389/fpubh.2017.00243. eCollection 2017.

6.

A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Rossi BM, Palmero EI, López-Kostner F, Sarroca C, Vaccaro CA, Spirandelli F, Ashton-Prolla P, Rodriguez Y, de Campos Reis Galvão H, Reis RM, Escremim de Paula A, Capochin Romagnolo LG, Alvarez K, Della Valle A, Neffa F, Kalfayan PG, Spirandelli E, Chialina S, Gutiérrez Angulo M, Castro-Mujica MDC, Sanchez de Monte J, Quispe R, da Silva SD, Rossi NT, Barletta-Carrillo C, Revollo S, Taborga X, Morillas LL, Tubeuf H, Monteiro-Santos EM, Piñero TA, Dominguez-Barrera C, Wernhoff P, Martins A, Hovig E, Møller P, Dominguez-Valentin M.

BMC Cancer. 2017 Sep 5;17(1):623. doi: 10.1186/s12885-017-3599-4.

7.

Management of Patients with Hereditary Colorectal Cancer Syndromes.

Brandão C, Lage J.

GE Port J Gastroenterol. 2015 Aug 14;22(5):204-212. doi: 10.1016/j.jpge.2015.06.003. eCollection 2015 Sep-Oct. Review.

8.

Recent developments in the treatment of metastatic colorectal cancer.

Loree JM, Kopetz S.

Ther Adv Med Oncol. 2017 Aug;9(8):551-564. doi: 10.1177/1758834017714997. Epub 2017 Jun 29. Review.

9.

Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.

Grosse SD, Gurrin LC, Bertalli NA, Allen KJ.

Genet Med. 2018 Apr;20(4):383-389. doi: 10.1038/gim.2017.121. Epub 2017 Aug 3. Review.

PMID:
28771247
10.

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.

Li P, Xiao Z, Braciak TA, Ou Q, Chen G, Oduncu FS.

PLoS One. 2017 Aug 2;12(8):e0181615. doi: 10.1371/journal.pone.0181615. eCollection 2017.

11.

Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome.

Luba DG, DiSario JA, Rock C, Saraiya D, Moyes K, Brown K, Rushton K, Ogara MM, Raphael M, Zimmerman D, Garrido K, Silguero E, Nelson J, Yurgelun MB, Kastrinos F, Wenstrup RJ, Syngal S.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):49-58. doi: 10.1016/j.cgh.2017.06.038. Epub 2017 Jun 28.

PMID:
28668538
12.

Identifying "ownership" through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome.

West KM, Burke W, Korngiebel DM.

Genet Med. 2017 Nov;19(11):1236-1244. doi: 10.1038/gim.2017.39. Epub 2017 May 4.

13.

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.

O'Kane GM, Ryan É, McVeigh TP, Creavin B, Hyland JM, O'Donoghue DP, Keegan D, Geraghty R, Flannery D, Nolan C, Donovan E, Mehigan BJ, McCormick P, Muldoon C, Farrell M, Shields C, Mulligan N, Kennedy MJ, Green AJ, Winter DC, MacMathuna P, Sheahan K, Gallagher DJ.

Cancer Med. 2017 Jun;6(6):1465-1472. doi: 10.1002/cam4.1025. Epub 2017 May 3.

14.

Impact of age and mismatch repair status on survival in colorectal cancer.

Li P, Xiao ZT, Braciak TA, Ou QJ, Chen G, Oduncu FS.

Cancer Med. 2017 May;6(5):975-981. doi: 10.1002/cam4.1007. Epub 2017 Mar 27.

15.

Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review.

Prince AE, Cadigan RJ, Henderson GE, Evans JP, Adams M, Coker-Schwimmer E, Penn DC, Van Riper M, Corbie-Smith G, Jonas DE.

Pharmgenomics Pers Med. 2017 Feb 20;10:49-60. doi: 10.2147/PGPM.S123808. eCollection 2017. Review.

16.

Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.

Chen W, Swanson BJ, Frankel WL.

Diagn Pathol. 2017 Mar 4;12(1):24. doi: 10.1186/s13000-017-0613-8. Review.

17.

Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.

Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, Rope AF, Davis JV, Bergen KM, Esterberg E, Muessig KR, Peterson SK, Syngal S, Acheson L, Wiesner G, Reiss J, Goddard KAB.

Fam Cancer. 2017 Jul;16(3):377-387. doi: 10.1007/s10689-017-9972-2.

18.

Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.

Hamilton JG, Abdiwahab E, Edwards HM, Fang ML, Jdayani A, Breslau ES.

J Gen Intern Med. 2017 Mar;32(3):315-324. doi: 10.1007/s11606-016-3943-4. Epub 2016 Dec 19. Review.

19.

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, Goldberg RM, Paskett E, Shields PG, Freudenheim JL, Stanich PP, Lattimer I, Arnold M, Liyanarachchi S, Kalady M, Heald B, Greenwood C, Paquette I, Prues M, Draper DJ, Lindeman C, Kuebler JP, Reynolds K, Brell JM, Shaper AA, Mahesh S, Buie N, Weeman K, Shine K, Haut M, Edwards J, Bastola S, Wickham K, Khanduja KS, Zacks R, Pritchard CC, Shirts BH, Jacobson A, Allen B, de la Chapelle A, Hampel H; Ohio Colorectal Cancer Prevention Initiative Study Group.

JAMA Oncol. 2017 Apr 1;3(4):464-471. doi: 10.1001/jamaoncol.2016.5194.

20.

Implementing Precision Medicine: The Ethical Challenges.

Korngiebel DM, Thummel KE, Burke W.

Trends Pharmacol Sci. 2017 Jan;38(1):8-14. doi: 10.1016/j.tips.2016.11.007. Epub 2016 Dec 7. Review.

Supplemental Content

Support Center